Parkinson's disease, also known as paralysis agitans, is a progressive 
degenerative disorder of the central nervous system, with onset usually between 
the ages of 50 and 65 years, and is associated with loss of dopaminergic neurons 
in the subsantia nigra and the presence of Lewy bodies. It is characterized by 
the triad of resting tremor, muscular rigidity and bradykinesia. 
Often-accompanying abnormalities include disorders of equilibrium, posture and 
autonomic function, including micturition. Symptoms from the lower urinary tract 
add a significant comorbidity factor in these patients. The incidence and 
prevalence of lower urinary tract dysfunction rise with increasing progression 
of the underlying neurological disease. They present a troublesome and difficult 
to treat health issue with a profound impact on the patient's quality of life. 
Storage symptoms seem to predominate. In the long term, renal function might be 
compromised, mainly as a result of elevated intravesical pressure. Various 
conservative, minimally-invasive and surgical treatment options are available to 
prevent harmful sequelae, and to improve the quality of life of these patients. 
We present an overview of current and prospective treatment strategies.